Japan-based Kaneka has acquired 96.8% shares in Israeli company EndoStream Medical (ESM), which manufactures cerebrovascular disease technologies.
This strategic move is aimed at bolstering the development of new medical devices, particularly for cerebrovascular treatment, including ESM’s Nautilus device for aneurysms.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
ESM’s technical expertise will be combined with Kaneka’s ‘manufacturing’ capabilities to develop the new devices.
Designed to treat cerebral aneurysms with wide openings, Nautilus gained regulatory approval in Europe last November and is expected to be approved and launched in the US market by early 2026 and in Japan in 2027.
Featuring a ‘special’ structure that allows it to be used alongside an aneurysm embolisation coil, Nautilus claims to offer a solution for challenging treatments that are not possible with existing solutions.
Kaneka’s diverse business portfolio includes devices for cardiac, peripheral vascular, and cerebrovascular diseases, as well as gastrointestinal tract disease treatments.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe company’s Health Care Solution Unit, which encompasses these medical businesses, is targeting sales of Y300bn by 2030.
Its existing cerebrovascular products include the i-ED COIL for preventing subarachnoid haemorrhage caused by cerebral aneurysms and Tigertriever, a device for cerebral thrombus retrieval in stroke cases.
The acquisition of ESM is expected to further enhance Kaneka’s product range and contribute to its growth, with a sales target exceeding Y20bn by 2030.
In January 2024, Kaneka established an exclusive distribution agreement in Japan with Israel-based Rapid Medical for Tigertriever.
Tigertriever incorporates a mechanism that enables the stent to be both opened and closed, facilitating the entanglement and retrieval of neurovascular blood clots while reducing the strain on blood vessels.
